Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The AAPS Journal|April 1, 2016
Sorafenib Decreases Tumor Exposure to an Anti-carcinoembryonic Antigen Monoclonal Antibody in a Mouse Model of Colorectal CancerVeena A Thomas, Joseph P Balthasar
Antibodies (Basel, Switzerland)|December 11, 2019
Understanding Inter-Individual Variability in Monoclonal Antibody DispositionVeena A Thomas, Joseph P Balthasar
Pharmacology & Therapeutics|May 21, 2020
The biodistribution of therapeutic proteins: Mechanism, implications for pharmacokinetics, and methods of evaluationKip P Conner, Siva Charan Devanaboyina, Veena A Thomas, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2019
Measurement and Quantitative Characterization of Whole-Body Pharmacokinetics of Exogenously Administered T Cells in MiceAntari Khot, Satoko Matsueda, Veena A Thomas, et al.
Mabs|April 21, 2020
Preclinical characterization of the ADME properties of a surrogate anti-IL-36R monoclonal antibody antagonist in mouse serum and tissuesKip P Conner, Cinthia V Pastuskovas, Marcus Soto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 22, 2023
Correlation of In Vitro Kinetic Stability to Preclinical In Vivo Pharmacokinetics for a Panel of Anti-PD-1 Monoclonal Antibody Interleukin 21 Mutein ImmunocytokinesKevin D Cook, Thuy Tran, Veena A Thomas, et al.
The AAPS Journal|April 7, 2026
Predicting Aberrant Fc-fusion Protein Pharmacokinetics from In Silico Structural Properties and Physiologically Based Pharmacokinetic (PBPK) ModelingDanilo Tomasoni, Alessio Paris, Roberto Visintainer, et al.
Mabs|October 12, 2023
Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in miceShufang Liu, Sara C Humphreys, Kevin D Cook, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2022
Hallmarks of neurodegenerative disease: A systems pharmacology perspectivePeter Bloomingdale, Tatiana Karelina, Vidya Ramakrishnan, et al.
Cell Reports. Medicine|June 7, 2021
GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeysShu-Chen Lu, Michelle Chen, Larissa Atangan, et al.
Pageof 2